In addition of the above-mentioned report by Darricau et al. (2024) that combined AD-tau with AβOs, five studies tested the effects of Aβ peptides or AβOs (as reported by the authors) in marmosets, rhesus macaques, cynomolgus macaques, and African green monkeys (Forny-Germano et al., 2014; Geula et al., 1998; Ridley et al., 2006; Wakeman et al., 2022; Yue et al., 2021) (Table 8). Here, MAPT is linked to Alzheimer disease.